AGL - agilon health, inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.02B
Enterprise Value 9.25B
Trailing P/E N/A
Forward P/E 172.41
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.11
Price/Book (mrq)9.25
Enterprise Value/Revenue 2.90
Enterprise Value/EBITDA -127.88

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 36.07%
S&P500 52-Week Change 31.77%
52 Week High 329.44
52 Week Low 315.00
50-Day Moving Average 325.12
200-Day Moving Average 321.72

Share Statistics

Avg Vol (3 month) 33.66M
Avg Vol (10 day) 37.48M
Shares Outstanding 5414.83M
Implied Shares Outstanding 6N/A
Float 8310.48M
% Held by Insiders 11.09%
% Held by Institutions 1106.14%
Shares Short (May 14, 2023) 437.21M
Short Ratio (May 14, 2023) 417.18
Short % of Float (May 14, 2023) 430.07%
Short % of Shares Outstanding (May 14, 2023) 48.97%
Shares Short (prior month Apr 13, 2023) 436.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin -2.88%
Operating Margin (ttm)-3.54%

Management Effectiveness

Return on Assets (ttm)-3.51%
Return on Equity (ttm)-8.40%

Income Statement

Revenue (ttm)3.19B
Revenue Per Share (ttm)7.76
Quarterly Revenue Growth (yoy)73.90%
Gross Profit (ttm)112.29M
EBITDA -98.35M
Net Income Avi to Common (ttm)-91.8M
Diluted EPS (ttm)-0.22
Quarterly Earnings Growth (yoy)1,202.60%

Balance Sheet

Total Cash (mrq)816.68M
Total Cash Per Share (mrq)1.97
Total Debt (mrq)52.72M
Total Debt/Equity (mrq)4.87
Current Ratio (mrq)1.93
Book Value Per Share (mrq)2.61

Cash Flow Statement

Operating Cash Flow (ttm)-168.39M
Levered Free Cash Flow (ttm)-143.91M